Next Article in Journal / Special Issue
The Release of Immunosuppressive Factor(s) in Young Males Following Exercise
Previous Article in Journal
Palmprint and Face Multi-Modal Biometric Recognition Based on SDA-GSVD and Its Kernelization
Previous Article in Special Issue
HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification
Sensors 2012, 12(5), 5572-5585; doi:10.3390/s120505572
Article

A Novel “Reactomics” Approach for Cancer Diagnostics

1,†
,
2,†
,
2
,
1
,
2
,
2
 and
2,*
1 Ilse Katz Institute for Nanoscale Science and Technology, Ben Gurion University of the Negev, Beer Sheva 84105, Israel 2 The Shraga Segal Department of Microbiology and Immunology and the National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, Beer Sheva 84105, Israel These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 3 February 2012 / Revised: 30 March 2012 / Accepted: 23 April 2012 / Published: 2 May 2012
View Full-Text   |   Download PDF [470 KB, uploaded 21 June 2014]   |   Browse Figures

Abstract

Non-invasive detection and monitoring of lethal diseases, such as cancer, are considered as effective factors in treatment and survival. We describe a new disease diagnostic approach, denoted reactomics”, based upon reactions between blood sera and an array of vesicles comprising different lipids and polydiacetylene (PDA), a chromatic polymer. We show that reactions between sera and such a lipid/PDA vesicle array produce chromatic patterns which depend both upon the sera composition as well as the specific lipid constituents within the vesicles. The chromatic patterns were processed through machine-learning algorithms, and the bioinformatics analysis could distinguish both between cancer-bearing and healthy patients, respectively, as well between two types of cancers. Size-separation and enzymatic digestion experiments indicate that lipoproteins are the primary components in sera which react with the chromatic biomimetic vesicles. This colorimetric reactomics concept is highly generic, robust, and does not require a priori knowledge upon specific disease markers in sera. Therefore, it could be employed as complementary or alternative approach for disease diagnostics.
Keywords: biomarker; cancer; serum; polydiacetylene; diagnostics; bioinformatics biomarker; cancer; serum; polydiacetylene; diagnostics; bioinformatics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplement

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Kolusheva, S.; Yossef, R.; Kugel, A.; Hanin-Avraham, N.; Cohen, M.; Rubin, E.; Porgador, A. A Novel “Reactomics” Approach for Cancer Diagnostics. Sensors 2012, 12, 5572-5585.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert